D'Angelo, S. P., Lebbé, C., Mortier, L., Brohl, A. S., Fazio, N., Grob, J., . . . Nghiem, P. (2021). First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Primary and biomarker analyses of a phase II study. J Immunother Cancer.
Citación estilo ChicagoD'Angelo, Sandra P., et al. "First-line Avelumab in a Cohort of 116 Patients With Metastatic Merkel Cell Carcinoma (JAVELIN Merkel 200): Primary and Biomarker Analyses of a Phase II Study." J Immunother Cancer 2021.
Cita MLAD'Angelo, Sandra P., et al. "First-line Avelumab in a Cohort of 116 Patients With Metastatic Merkel Cell Carcinoma (JAVELIN Merkel 200): Primary and Biomarker Analyses of a Phase II Study." J Immunother Cancer 2021.